Effects of Telehealth Initiative on Lupus Patients
Systemic Lupus Erythematosus
About this trial
This is an interventional supportive care trial for Systemic Lupus Erythematosus focused on measuring Life activities, Pain, Happiness
Eligibility Criteria
Inclusion Criteria:
- Those between the ages of 18-45,
- Diagnosed with SLE disease
- Those who are in remission of the disease
- Those who do not use biological DMARDs
- Non-smokers
- Those who do not drink alcohol
- Those with low disease activity score,
- Neurological, psychiatric disease and non-malignant,
- Individuals who are literate, able to communicate verbally and agree to participate in the study, among those evaluated and approved by their physicians.
Exclusion Criteria:
- Having a chronic disease other than SLE
- Having a rheumatological disease other than SLE
- Having a disability to use the phone
- Those with hearing loss or visual impairment,
- Those who have undergone changes in the treatment process and those who practice non-drug therapy during the study will not be included in the study.
In determining the inclusion, exclusion and termination criteria, both the literature and the consultation of a specialist in the field were taken.
Sites / Locations
- Selcuk University Hospital
Arms of the Study
Arm 1
Arm 2
Experimental
No Intervention
Experimental
Control
Patients will be asked to fill out the Introductory Information Form, the Numerical Rating Scale, the Oxford Happiness Scale Short Form, and the Life Activities Scale scales. Then, the educational needs of the patients in the experimental group will be determined. Trainings will be planned individually for each patient according to the needs of the patients. After the patients go to their homes, telehealth will be implemented. Patients included in the experimental group will continue their routine physician appointments and prescriptions. In addition, telehealth education initiative will be made for the patients. Structured training will be applied to the patients once a week for 12 weeks, each training will be 20-40 minutes. The researcher will develop a trusting relationship with the patient and evaluate the patient's compliance with treatment, obstacles to happiness, information needs related to pain management, and difficulties in life activities.
No application will be made by the researcher to the patients in the control group. Patients will continue with their prescriptions and physician visit routines. The scales will be administered to the patients in this group at the beginning of the study and at the 4th, 8th, and 12th weeks.